$CUR Headlines Neuralstem gets FDA okay for depr

$CUR Headlines

Neuralstem gets FDA okay for depression study 10:28 a.m. Oct. 17, 2012 - MarketWatch.com
Stocks to watch Monday: LDK, OfficeMax 5:27 p.m. Sept. 14, 2012 - William Spain
Friday’s biggest gaining and declining stocks 5:11 p.m. Sept. 14, 2012 - MarketWatch
Hot stocks to watch 7:14 a.m. Sept. 14, 2012 - MarketWatch.com
Stocks to watch Friday: Werner, Libbey, Delphi 7:07 a.m. Sept. 14, 2012 - MarketWatch
Canada hot stocks: Scotiabank, Great Panther 3:29 p.m. Aug. 30, 2011 - MarketWatch
Are stem-cell stocks a good buy? 3:06 p.m. July 13, 2011 - Val Brickates Kennedy
Drug stocks mixed after Fed statement 2:02 p.m. June 22, 2011 - Val Brickates Kennedy
Drug stocks gain while Nanosphere sinks 2:12 p.m. June 21, 2011 - Val Brickates Kennedy
Neuralstem soars on FDA move 3:00 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Neuralstem, Impax in drug-sector spotlight 4:22 p.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem climbs as drug indexes hug flat line 11:02 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem soars on FDA nod 10:16 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Before the Close Report from the MarketWatch Radio Network 2:31 p.m. March 9, 2009 - Andrew O'Day
Geron's study OK signals progress for company, stem cell peers 2:13 p.m. Jan. 23, 2009 - MarketWatch.com
2007 could emerge as a pivotal year for stem-cell investing 6:43 p.m. Dec. 12, 2007 - Scott Austin
Palatin plunges on drug setback; Atherogenics continues rally 1:42 p.m. Aug. 30, 2007 - Val Brickates Kennedy
Neuralstem teams up with U Mich. for ALS research 9:26 a.m. Aug. 30, 2007 - Val Brickates Kennedy
Stem cell industry trying to see silver lining in funding fight 12:36 p.m. April 13, 2007 - Greg Presto

Neuralstem And Brainstorm Cell Therapeutics: The Race To Treat ALS 10:30 a.m. Today - Seeking Alpha
Osiris Therapeutics: Poised For Another Breakout 2:07 a.m. Today - Seeking Alpha
Major stem cell discovery might not be so major 2:32 p.m. March 10, 2014 - Seeking Alpha
10-K: NEURALSTEM, INC. 6:29 a.m. March 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
An Early Valuation Of Neuralstem's NSI566 9:25 a.m. Feb. 28, 2014 - Seeking Alpha
First Week Of April 19th Options Trading For Neuralstem (CUR) 12:32 p.m. Feb. 25, 2014 - TheStreet.com
Neuralstem Phase 1 Data Gives Hope In ALS 11:46 a.m. Feb. 18, 2014 - Seeking Alpha
StemCells, Inc., And Neuralstem, Inc.: A Side-By-Side Analysis 1:17 p.m. Jan. 31, 2014 - Seeking Alpha
Neuralstem: Sizing Up Potential Key Events Of 2014 8:05 a.m. Jan. 28, 2014 - Seeking Alpha
Neuralstem, StemCells, Inc., And Athersys, Inc. - Making Early Headlines In 2014 9:30 a.m. Jan. 24, 2014 - Seeking Alpha
Notes From One-On-One Meetings During San Fran Biotech Week - Day 1 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
China Biotech In Review: Thermo Fisher Approved For Acquisition Of Life Technologies 2:07 a.m. Jan. 19, 2014 - Seeking Alpha
Neuralstem Reports First Patient Treated In China Stem Cell Trial to Treat Stroke Motor Deficits 8:49 a.m. Jan. 13, 2014 - benzinga.com
StemCells CEO Writes Letter To Shareholders, Identifies Upcoming Catalysts 2:14 p.m. Jan. 10, 2014 - Seeking Alpha
Organovo Currently Has Nothing In The Works For Tissue Implantation -- Its Main Value Driver 11:05 a.m. Jan. 10, 2014 - Seeking Alpha
Vital Stem Cell Data And Development Coming In 2014 4:26 a.m. Jan. 10, 2014 - Seeking Alpha
Positive Signs From Neuralstem's Phase 2 ALS Trial 12:03 p.m. Jan. 6, 2014 - Seeking Alpha
Athersys: Remarkable Treatment For Ischemic Stroke Feasibly On The Way 10:43 a.m. Jan. 5, 2014 - Seeking Alpha
Neuralstem announces offering, shares fall 10:46 a.m. Jan. 3, 2014 - Seeking Alpha
A Glance At Our Winners And Losers In 2013 5:22 p.m. Dec. 31, 2013 - Seeking Alpha


Discovery Could Lead to Major Breakthrough in Alzheimer's Disease and Other Brain Disorders 2:31 p.m. March 5, 2014 - ACCESSWIRE
Neuralstem, Inc. "Right to Try" 10:45 a.m. March 3, 2014 - ACCESSWIRE
Neuralstem President and CEO to Present NSI-566 Clinical Trials Program Update at BIO CEO & Investor Conference 2014 10:00 a.m. Feb. 6, 2014 - PR Newswire - PRF
RBCC Explores New Contacts in Personalized Medicine and Drug Delivery 8:54 a.m. Jan. 22, 2014 - BusinessWire - BZX
Neuralstem President And CEO To Present 2014 Trials Overview At 2014 Biotech Showcase 4:50 p.m. Jan. 13, 2014 - PR Newswire - PRF
First Patient Treated In Neuralstem China Stem Cell Trial To Treat Stroke Motor Deficits 10:46 a.m. Jan. 13, 2014 - PR Newswire - PRF
Neuralstem Closes $20 Million Registered Direct Offering 10:00 a.m. Jan. 9, 2014 - PR Newswire
Neuralstem To Raise $19.65 Million In Registered Direct Offering 10:00 a.m. Jan. 3, 2014 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog 1:15 p.m. Dec. 3, 2013 - ACCESSWIRE
RBCC: Stem Cell Breakthrough Could Eliminate Lung Transplants 6:00 a.m. Dec. 3, 2013 - BusinessWire
RBCC Moves Forward With Regenerative Medicine Negotiations 6:00 a.m. Nov. 21, 2013 - BusinessWire
RBCC Narrows List of Regenerative Medicine Targets 6:00 a.m. Nov. 13, 2013 - BusinessWire
Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update 5:46 p.m. Nov. 12, 2013 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog 10:45 a.m. Oct. 31, 2013 - ACCESSWIRE
Dr. Eva Feldman, Principal Investigator, to Give Update on ALS Trial at American Neurological Association Meeting 9:15 a.m. Oct. 10, 2013 - PR Newswire
University Of Michigan Health System Treats Its First Patients In Neuralstem's Phase II ALS Stem Cell Trial 9:15 a.m. Oct. 9, 2013 - PR Newswire
Neuralstem CEO To Present At Stem Cells & Regenerative Medicine Congress 9:15 a.m. Sept. 26, 2013 - PR Newswire
Neuralstem, Inc. President and CEO Publishes New Blog Entitled â??An ounce of action is worth a ton of theoryâ? 3:03 p.m. Sept. 16, 2013 - ACCESSWIRE
First Patient Treated In Phase II Of Neuralstem ALS Stem Cell Trial 9:15 a.m. Sept. 10, 2013 - PR Newswire
Neuralstem To Raise $4 Million In Registered Direct Offering 7:00 a.m. Sept. 5, 2013 - PR Newswire